{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36939560", "DateCompleted": {"Year": "2023", "Month": "11", "Day": "03"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "06"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "03", "Day": "20"}], "Language": ["eng"], "ELocationID": ["10.1097/FBP.0000000000000721"], "Journal": {"ISSN": "1473-5849", "JournalIssue": {"Volume": "34", "Issue": "8", "PubDate": {"Year": "2023", "Month": "Dec", "Day": "01"}}, "Title": "Behavioural pharmacology", "ISOAbbreviation": "Behav Pharmacol"}, "ArticleTitle": "The role of l -arginine/NO/cGMP/K ATP channel pathway in the local antinociceptive effect of berberine in the rat formalin test.", "Pagination": {"StartPage": "449", "EndPage": "456", "MedlinePgn": "449-456"}, "Abstract": {"AbstractText": ["Berberine is an isoquinoline alkaloid naturally produced by several types of plants. Berberine has extensive pharmacological effects, such as anti-diabetic, anti-inflammatory, and antioxidant effects. In the current study, we assess the antinociceptive effects of berberine and its association with the l -arginine ( l -Arg)/NO/cGMP/K ATP channel pathway via intraplantar administration in rats. To examine the antinociceptive properties of berberine, the formalin test was conducted. The number of rat paw flinches was counted for an h. l -Arg (precursor of nitric oxide, 3-30\u2009 \u03bc g/paw), l -NAME (NO synthase inhibitor, 10 and 100\u2009 \u03bc g/paw), methylene blue (guanylyl cyclase inhibitor, 100 and 200\u2009 \u03bc g/paw), and glibenclamide (ATP-sensitive potassium channel blocker, 10 and 30\u2009 \u03bc g/paw) were locally injected, respectively, into the right hind paws of rats as a pre-treatment before berberine injection to understand how the l -Arg/NO/cGMP/K ATP pathway plays a role in the antinociceptive effect of berberine. The ipsilateral injection of berberine into the right paw (0.1-10 0 \u2009 \u03bc g/paw) showed a dose-dependent antinociceptive effect in both the first and second phases of the formalin test, almost similar to morphine (25\u2009 \u03bc g/paw). Intraplantar injection of l -Arg (30\u2009\u00b5g/paw) increased the antinociceptive effect of berberine in the second phase. In addition, injection of l -NAME, methylene blue, and glibenclamide caused a reduction in the antinociceptive effect of berberine throughout the second phase in a dose-dependent manner. However, the antinociceptive effects of berberine in the first phase of the rat formalin test were not affected by this pathway. As a novel local antinociceptive agent, berberine can exert a peripheral antinociceptive effect via the l -Arg/NO/cGMP/K ATP channel pathway."], "CopyrightInformation": "Copyright \u00a9 2023 Wolters Kluwer Health, Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee."}], "LastName": "Rahemi", "ForeName": "Milad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee."}, {"Identifier": [], "Affiliation": "Medicinal Plant Research Center."}], "LastName": "Mohtadi", "ForeName": "Shokooh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Pharmacy."}], "LastName": "Rajabi Vardanjani", "ForeName": "Hossein", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Toxicology Research Center, Medical Basic Sciences Research Institute."}, {"Identifier": [], "Affiliation": "Department of Toxicology, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran."}], "LastName": "Khodayar", "ForeName": "Mohammad Javad", "Initials": "MJ"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Behav Pharmacol", "NlmUniqueID": "9013016", "ISSNLinking": "0955-8810"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Analgesics"}, {"RegistryNumber": "0I8Y3P32UF", "NameOfSubstance": "Berberine"}, {"RegistryNumber": "T42P99266K", "NameOfSubstance": "Methylene Blue"}, {"RegistryNumber": "SX6K58TVWC", "NameOfSubstance": "Glyburide"}, {"RegistryNumber": "0", "NameOfSubstance": "KATP Channels"}, {"RegistryNumber": "94ZLA3W45F", "NameOfSubstance": "Arginine"}, {"RegistryNumber": "V55S2QJN2X", "NameOfSubstance": "NG-Nitroarginine Methyl Ester"}, {"RegistryNumber": "H2D2X058MU", "NameOfSubstance": "Cyclic GMP"}, {"RegistryNumber": "8L70Q75FXE", "NameOfSubstance": "Adenosine Triphosphate"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Analgesics"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Berberine"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Methylene Blue"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": [], "DescriptorName": "Pain Measurement"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Glyburide"}, {"QualifierName": ["metabolism"], "DescriptorName": "KATP Channels"}, {"QualifierName": ["pharmacology", "metabolism"], "DescriptorName": "Arginine"}, {"QualifierName": ["pharmacology"], "DescriptorName": "NG-Nitroarginine Methyl Ester"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cyclic GMP"}, {"QualifierName": [], "DescriptorName": "Adenosine Triphosphate"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abbasnezhad A, Khazdair MR, Kianmehr M (2016). The role of nitric oxide on the oxytocin induce analgesia in mice. Iran J Basic Med Sci 19:238\u2013244."}, {"Citation": "Abboud C, Duveau A, Bouali-Benazzouz R, Mass\u00e9 K, Mattar J, Brochoire L, et al. (2021). Animal models of pain: diversity and benefits. J Neurosci Methods 348:108997."}, {"Citation": "Abd El-Wahab AE, Ghareeb DA, Sarhan EE, Abu-Serie MM, El Demellawy MA (2013). In vitro biological assessment of Berberis vulgaris and its active constituent, berberine: antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects. BMC Complement Med Ther 13:218."}, {"Citation": "Afify EA, Khedr MM, Omar AG, Nasser SA (2013). The involvement of K ATP channels in morphine-induced antinociception and hepatic oxidative stress in acute and inflammatory pain in rats. Fundam Clin Pharmacol 27:623\u2013631."}, {"Citation": "Alizamani E, Ghorbanzadeh B, Naserzadeh R, Mansouri MT (2021). Montelukast, a cysteinyl leukotriene receptor antagonist, exerts local antinociception in animal model of pain through the L-arginine/nitric oxide/cyclic GMP/KATP channel pathway and PPAR\u03b3 receptors. Int J Neurosci 131:1004\u20131011."}, {"Citation": "Barrot M (2012). Tests and models of nociception and pain in rodents. Neuroscience 211:39\u201350."}, {"Citation": "Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, et al. (2008). Opioid complications and side effects. Pain Physician 11:S105\u2013S120."}, {"Citation": "Brito GA, Sachs D, Cunha FQ, Vale ML, Lotufo CM, Ferreira SH, et al. (2006). Peripheral antinociceptive effect of pertussis toxin: activation of the arginine/NO/cGMP/PKG/ATP-sensitive K+ channel pathway. Eur J Neurosci 24:1175\u20131181."}, {"Citation": "Cury Y, Picolo G, Gutierrez VP, Ferreira SH (2011). Pain and analgesia: the dual effect of nitric oxide in the nociceptive system. Nitric Oxide 25:243\u2013254."}, {"Citation": "Dubuisson D, Dennis SG (1977). The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4:161\u2013174."}, {"Citation": "Fakhri S, Ahmadpour Y, Rezaei H, Kooshki L, Moradi SZ, Iranpanah A, et al. (2020). The antinociceptive mechanisms of melatonin: role of L-arginine/nitric oxide/cyclic GMP/KATP channel signaling pathway. Behav Pharmacol 31:728\u2013737."}, {"Citation": "Ghorbanzadeh B, Mansouri MT, Hemmati AA, Naghizadeh B, Mard SA, Rezaie A (2014). Involvement of L-arginine/NO/cGMP/KATP channel pathway in the peripheral antinociceptive actions of ellagic acid in the rat formalin test. Pharmacol Biochem Behav 126:116\u2013121."}, {"Citation": "Ghorbanzadeh B, Mansouri MT, Naghizadeh B, Alboghobeish S (2018). Local antinociceptive action of fluoxetine in the rat formalin assay: role of l-arginine/nitric oxide/cGMP/KATP channel pathway. Can J Physiol Pharmacol 96:165\u2013172."}, {"Citation": "Ghorbanzadeh B, Kheirandish V, Mansouri MT (2019). Involvement of the L-arginine/Nitric Oxide/Cyclic GMP/KATP channel pathway and PPAR\u03b3 receptors in the peripheral antinociceptive effect of carbamazepine. Drug Res (Stuttg) 69:650\u2013657."}, {"Citation": "Han S, Yan R-B, Guan S, Fan W-J, Chu H-C, Liang Y-X (2021). Current research progress in identifying the mechanism of berberine in pain regulation. Pharmacol Res Modern Chin Med 1:100019."}, {"Citation": "Hashemzaei M, Rezaee R (2021). A review on pain-relieving activity of berberine. Phytother Res 35:2846\u20132853."}, {"Citation": "Horst BG, Yokom AL, Rosenberg DJ, Morris KL, Hammel M, Hurley JH, et al. (2019). Allosteric activation of the nitric oxide receptor soluble guanylate cyclase mapped by cryo-electron microscopy. eLife 8:e50634."}, {"Citation": "Kawabata A, Fukuzumi Y, Fukushima Y, Takagi H (1992). Antinociceptive effect of L-arginine on the carrageenin-induced hyperalgesia of the rat: possible involvement of central opioidergic systems. Eur J Pharmacol 218:153\u2013158."}, {"Citation": "Kawabata A, Manabe S, Manabe Y, Takagi H (1994). Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br J Pharmacol 112:547\u2013550."}, {"Citation": "Kilic FS, Sirmagul B, Yildirim E, Oner S, Erol K (2012). Antinociceptive effects of gabapentin & its mechanism of action in experimental animal studies. Indian J Med Res 135:630\u2013635."}, {"Citation": "Koch K (2012). Acute pain management in general practice: steps to effective pain control. S Afr Fam Pract 54:189\u2013191."}, {"Citation": "Koohsari S, Sheikholeslami MA, Parvardeh S, Ghafghazi S, Samadi S, Poul YK, et al. (2020). Antinociceptive and antineuropathic effects of cuminaldehyde, the major constituent of Cuminum cyminum seeds: possible mechanisms of action. J Ethnopharmacol 255:112786."}, {"Citation": "Kosalec I, Gregurek B, Kremer D, Zovko Kon\u010di\u0107 M, Sankovi\u0107 K, Karlovic K (2009). Croatian barberry (Berberis croatica Horvat): a new source of berberine - analysis and antimicrobial activity. World J Microbiol Biotechnol 25:145\u2013150."}, {"Citation": "Kulkarni S, Dhir A (2007). Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride. Eur J Pharmacol 569:77\u201383."}, {"Citation": "Kuo CL, Chi CW, Liu TY (2004). The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 203:127\u2013137."}, {"Citation": "Li Y, Yin Y-M, Wang X-Y, Wu H, Ge X-Z (2018). Evaluation of berberine as a natural fungicide: biodegradation and antimicrobial mechanism. J Asian Nat Prod Res 20:148\u2013162."}, {"Citation": "Lopes DM, Cater HL, Thakur M, Wells S, McMahon SB (2019). A refinement to the formalin test in mice. F1000Res 8:891."}, {"Citation": "Mansouri MT, Naghizadeh B, Ghorbanzadeh B, Farbood Y (2013). Central and peripheral antinociceptive effects of ellagic acid in different animal models of pain. Eur J Pharmacol 707:46\u201353."}, {"Citation": "Mart\u00ednez-Rojas VA, Garc\u00eda G, Noriega-Navarro R, Guzm\u00e1n-Priego CG, Torres-L\u00f3pez JE, Granados-Soto V, et al. (2018). Peripheral and spinal TRPA1 channels contribute to formalin-induced long-lasting mechanical hypersensitivity. J Pain Res 11:51\u201360."}, {"Citation": "McNamara CR, Mandel-Brehm J, Bautista DM, Siemens J, Deranian KL, Zhao M, et al. (2007). TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci USA 104:13525\u201313530."}, {"Citation": "Mehanna MM, Domiati S, Chmaisse HN, El Mallah A (2018). Antinociceptive effect of tadalafil in various pain models: involvement of opioid receptors and nitric oxide cyclic GMP pathway. Toxicol Appl Pharmacol 352:170\u2013175."}, {"Citation": "Miclescu A, Gordh T (2009). Nitric oxide and pain: \u2018Something old, something new\u2019. Acta Anaesthesiol Scand 53:1107\u20131120."}, {"Citation": "Nurcan B, Rana A (2017). The involvement of NO-cGMP-ATP sensitive K+ channels pathway in protocatechuic acid peripheral analgesia. Indian J Pharm Educ Res 51."}, {"Citation": "Oca\u00f1a M, Cend\u00e1n CM, Cobos EJ, Entrena JM, Baeyens JM (2004). Potassium channels and pain: present realities and future opportunities. Eur J Pharmacol 500:203\u2013219."}, {"Citation": "Okuducu H, Onal SA (2005). Is nitric oxide involved in the antinociceptive activity of tramadol? Findings in a rat model of neuropathic pain. Agri 17:31\u201340."}, {"Citation": "Ortiz MI, Cari\u00f1o-Cort\u00e9s R, Casta\u00f1eda-Hern\u00e1ndez G (2020). Participation of the opioid receptor\u2013nitric oxide\u2013cGMP\u2013K+ channel pathway in the peripheral antinociceptive effect of nalbuphine and buprenorphine in rats. Can J Physiol Pharmacol 98:753\u2013762."}, {"Citation": "Parvardeh S, Sabetkasaei M, Moghimi M, Masoudi A, Ghafghazi S, Mahboobifard F (2018). Role of L-Arginine/NO/cGMP/KATP channel signaling pathway in the central and peripheral antinociceptive effect of thymoquinone in rats. Iran J Basic Med Sci 21:625\u2013633."}, {"Citation": "Prajwala B, Raghu N, Gopenath T, Shanmukhappa B, Karthikeyan M, Ashok G, et al. (2020). Berberine and its pharmacology potential: a review. Eur J Biomed 7:115\u2013123."}, {"Citation": "Soares AC, Leite R, Tatsuo MA, Duarte ID (2000). Activation of ATP-sensitive K+ channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside. Eur J Pharmacol 400:67\u201371."}, {"Citation": "Song D, Hao J, Fan D (2020). Biological properties and clinical applications of berberine. Front Med 14:564\u2013582."}, {"Citation": "Stefano F, Distrutti E (2007). Cyclo-oxygenase (COX) inhibiting nitric oxide donating (CINODs) drugs: a review of their current status. Curr Top Med Chem 7:277\u2013282."}, {"Citation": "Tang QL, Lai ML, Zhong YF, Wang AM, Su JK, Zhang MQ (2013). Antinociceptive effect of berberine on visceral hypersensitivity in rats. World J Gastroenterol 19:4582\u20134589."}, {"Citation": "Tsiklauri N, Pirkulashvili N, Nozadze I, Nebieridze M, Gurtskaia G, Abzianidze E, et al. (2018). Antinociceptive tolerance to NSAIDs in the anterior cingulate cortex is mediated via endogenous opioid mechanism. BMC Pharmacol Toxicol 19:1\u20137."}, {"Citation": "Wang Y, Huang Y, Lam K, Li Y, Wong WT, Ye H, et al. (2009). Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. Cardiovasc Res 82:484\u2013492."}, {"Citation": "Yan Y, Li X, Zhang C, Lv L, Gao B, Li M (2021). Research progress on antibacterial activities and mechanisms of natural alkaloids: a review. Antibiotics 10:318."}, {"Citation": "Yoon MH, Choi JI, Bae HB, Jeong SW, Chung SS, Yoo KY, et al. (2005). Lack of the nitric oxide-cyclic GMP-potassium channel pathway for the antinociceptive effect of intrathecal zaprinast in a rat formalin test. Neurosci Lett 390:114\u2013117."}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "11", "Day": "3", "Hour": "6", "Minute": "44"}, {"Year": "2023", "Month": "3", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "20", "Hour": "10", "Minute": "53"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36939560", "10.1097/FBP.0000000000000721", "00008877-990000000-00040"]}}], "PubmedBookArticle": []}